PHAR3912 - Severe Dermatitis

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/9

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

10 Terms

1
New cards

what are the Dx criteria for severe dermatitis?

Inflammatory response of the skin

redness, rash, itchy

atopic (eczema) = chronic + genetic

EASI score >20

frequent flares

2
New cards

what factors can lead to poor control or Tx resistance to atopic dermatitis?

non-adherence

incorrect application

allergy triggers

depression

lack of education

other conditions

3
New cards

what are common misconceptions of topical corticosteroid use?

1. application to cracked skin - can do

2. stunts growth - no

3. skin pigment change - no eczema can decrease melanin tho

4. moisturizer only - no

5. small sparingly - no, liberally

4
New cards

what is topical steroid withdrawal (TSW) Sx and Tx?

rebound reaction from TCS overuse

Sx: burning, weeping, red sleeve pattern, swelling

Tx: discontinue TCS

5
New cards

what are the THREE modified dressings for dermatitis?

1. wet dressing: bath, pat dry, TCS, wet dressing 60 mins 5-7d

2. soak and smear: bath, no dry, TCS, no dry, 4-14d

3. occlusion: clean, TCS, plastic wrap overnight

6
New cards

what is the use of phototherapy in severe dermatitis?

UVB -> inhibit immune inflammation pathways

2-3/wk for months (low adherence)

conjunction with topical therapy

7
New cards

what oral medication is used for severe dermatitis Tx?

1. ciclosporin: short-term, by weight dose, immunosuppression risks

2. methotrexate: off-label, long term, weekly dosing, 2-3m to see effect

3. azathioprine: off-label, by weight dosing, 1-2m to see effect

4. mycophenolate mofetil: off-label, no response to ciclosporin or azathioprine

5. upadacitinib: JAK inhibitor, 1m to see effect, immunosuppression

8
New cards

explain dupilumab as a biological therapy for severe dermatitis (MOA, criteria,

mAb (biologic) therapy

MOA: targets immunomodulators -> inhibit IL4/13 signaling -> stops type 2 inflammation -> stops overreaction

criteria: >12 with chronic severe eczema, Tx failure

9
New cards

what is the pharmacists role in severe dermatitis?

eczema care plan

education + myth debunk

use of TCS

therapy escalation discussions

10
New cards

what is the role of adjuvant therapy in severe dermatitis management?

antihistamines, oral corticosteroids

in combination with optimal skin care + topical measures (bleach baths) + wet wraps during flares